GANX NASDAQ
Gain Therapeutics, Inc.
1W: -3.9%
1M: -4.5%
3M: -5.5%
YTD: -46.2%
1Y: -6.0%
3Y: -46.7%
5Y: -77.0%
$1.71
-0.01 (-0.58%)
Weekly Expected Move ±7.2%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-11-22
Earliest Filing
2025-07-17
Latest Filing
partner: 5
Counterparties (Filed by GANX)
5 relationshipsCompanies named in GANX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Pacific Stock Transfer Company | — | partner | Warrant agent for the offering | 2025-07-17 | View |
| Oppenheimer & Co. Inc. | OPY | partner | Agent for at-the-market offering program | 2024-09-06 | View |
| Titan Partners Group LLC | KMCM | partner | Underwriter for the offering of common stock and pre-funded warrants. | 2024-06-14 | View |
| American Capital Partners, LLC | AIG | partner | Parent company of Titan Partners Group LLC, the underwriter. | 2024-06-14 | View |
| Pacific Stock Transfer Company | — | partner | Appointed as the warrant agent for the offering. | 2023-11-22 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Other Events | View | |
| 2026-09-28 | Officer/Director Change | View | |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-07-16 | Other Events | View | |
| 2026-06-29 | Other Events | View | |
| 2026-06-25 | Shareholder Vote | View | |
| 2026-05-26 | Other Events | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-02-03 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-18 | Other Events | View | |
| 2025-11-28 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-14 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-09 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-06 | Other Events | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-17 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-06-30 | Other Events | View | |
| 2025-06-24 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR